These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase. Ngamelue MN; Homma K; Lockridge O; Asojo OA Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Sep; 63(Pt 9):723-7. PubMed ID: 17768338 [TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase. Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215 [TBL] [Abstract][Full Text] [Related]
7. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity. Duysen EG; Bartels CF; Lockridge O J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740 [TBL] [Abstract][Full Text] [Related]
8. Tetramerization domain of human butyrylcholinesterase is at the C-terminus. Blong RM; Bedows E; Lockridge O Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):747-57. PubMed ID: 9581552 [TBL] [Abstract][Full Text] [Related]
9. Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents. Wandhammer M; Carletti E; Van der Schans M; Gillon E; Nicolet Y; Masson P; Goeldner M; Noort D; Nachon F J Biol Chem; 2011 May; 286(19):16783-9. PubMed ID: 21454498 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study. Rosenberry TL; Brazzolotto X; Macdonald IR; Wandhammer M; Trovaslet-Leroy M; Darvesh S; Nachon F Molecules; 2017 Nov; 22(12):. PubMed ID: 29186056 [TBL] [Abstract][Full Text] [Related]
15. New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors. Ronco C; Foucault R; Gillon E; Bohn P; Nachon F; Jean L; Renard PY ChemMedChem; 2011 May; 6(5):876-88. PubMed ID: 21344648 [TBL] [Abstract][Full Text] [Related]
16. His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases. Ralph EC; Xiang L; Cashman JR; Zhang J Protein Expr Purif; 2011 Nov; 80(1):22-7. PubMed ID: 21802514 [TBL] [Abstract][Full Text] [Related]
17. Proline-Rich Chaperones Are Compared Computationally and Experimentally for Their Abilities to Facilitate Recombinant Butyrylcholinesterase Tetramerization in CHO Cells. Wang Q; Chen CH; Chung CY; Priola J; Chu JH; Tang J; Ulmschneider MB; Betenbaugh MJ Biotechnol J; 2018 Mar; 13(3):e1700479. PubMed ID: 29024569 [TBL] [Abstract][Full Text] [Related]
19. Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Rosenberg YJ; Saxena A; Sun W; Jiang X; Chilukuri N; Luo C; Doctor BP; Lee KD Chem Biol Interact; 2010 Sep; 187(1-3):279-86. PubMed ID: 20211615 [TBL] [Abstract][Full Text] [Related]
20. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase. Boeck AT; Schopfer LM; Lockridge O Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]